GSK Creates a Future-Ready Supply Chain with Predictive and Prescriptive Maintenance
GlaxoSmithKline (GSK) implemented Aspen Mtell® to increase the robustness of their pharma supply chains by preventing unplanned production downtime.
With Aspen Mtell, GSK saw the following results:
- 35 days’ advance warning of potential issues
- Tens of millions of USD in lost batches avoided
- 50% reduction in lifecycle maintenance costs
- 30 sites across 18 countries covered, multiplying value gained
Learn more about how AspenTech’s technology empowers GSK to create a reliable, future-ready supply chain.
Related Content
In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to supply. So how can companies maintain the security of supply while protecting profits?
Video:
Aspen Mtell for Pharmaceuticals - What is an Agent?
Executive Brief:
Optimizing Outcomes Across the Pharma Value Chain Network
Video:
Optimizing Outcomes Across the Pharma Value Chain Network